Ziff Capital Partners logo

Ziff Capital Partners

North America, New York, United States, New York

Description

Ziff Capital Partners is a venture capital firm focused on investment strategy and execution and works with portfolio companies.

Investor Profile

Ziff Capital Partners has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 22% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series B (44%)
  • Series A (33%)
  • Series C (22%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Ediscovery
  • Product Research
  • Medical
  • Therapeutics
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Ziff Capital Partners frequently co-invest with?

Amgen
North America, California, United States, Thousand Oaks
Co-Investments: 1
Boston Millennia Partners
North America, Massachusetts, United States, Boston
Co-Investments: 1
Bain Capital Life Sciences
North America, Massachusetts, United States, Boston
Co-Investments: 2
Magnetar Capital
North America, Illinois, United States, Evanston
Co-Investments: 2
Viking Global Investors
North America, Connecticut, United States, Stamford
Co-Investments: 2
Millennium Management
North America, New York, United States, New York
Co-Investments: 1
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
IV
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 1

Which angels does Ziff Capital Partners often collaborate with?

GR
North America, New York, United States, New York
Shared Deals: 1
RH
North America, California, United States, San Francisco
Shared Deals: 1
EA
North America, New Hampshire, United States, Portsmouth
Shared Deals: 1
Dan Rosensweig
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Ziff Capital Partners?

Corner Therapeutics

Watertown, Massachusetts, United States

Corner Therapeutics is a biotechnology research company that specializes in the immunotherapy paradigm.

BiotechnologyHealth CareLife Science
Series AApr 18, 2024
Amount Raised: $54,000,000
Platelet BioGenesis

Watertown, Massachusetts, United States

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

BiotechnologyEdiscoveryLife ScienceProduct Research
Series BNov 4, 2021
Amount Raised: $75,500,000
Mighty Networks

Palo Alto, California, United States

The most popular all-in-one community platform for creators and entrepreneurs. $370M in creator earnings in 2023

CommunitiesE-CommercePrivate Social NetworkingProfessional NetworkingSoftware
Series BApr 26, 2021
Amount Raised: $50,000,000
Affinivax

Cambridge, Massachusetts, United States

Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series CJan 8, 2021
Amount Raised: $226,000,000
SomaLogic

Boulder, Colorado, United States

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series ADec 23, 2020
Amount Raised: $81,000,000
Imvax

Philadelphia, Pennsylvania, United States

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

BiotechnologyPharmaceuticalTherapeutics
Series CJul 16, 2020
Amount Raised: $112,000,000
Affinivax

Cambridge, Massachusetts, United States

Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Series BApr 23, 2020
Amount Raised: $120,000,000
Imvax

Philadelphia, Pennsylvania, United States

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

BiotechnologyPharmaceuticalTherapeutics
Series BSep 10, 2019
Amount Raised: $40,000,000
Platelet BioGenesis

Watertown, Massachusetts, United States

Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.

BiotechnologyEdiscoveryLife ScienceProduct Research
Series ASep 9, 2019
Amount Raised: $26,000,000